CareLit Fachartikel
Evaluation of Tuberculosis Risk under Interleukin-1 Inhibitor Agents in Patients with Autoinflammatory Diseases: Experience from a Region with Moderate Tuberculosis Prevalence
Özlem Karakaş, İsmail Dogan, Serdar Can Güven, Şule Erel, Sukran Erten · Aktuelle Rheumatologie · 2024 · Heft 01 · S. 49-53
Dokument
893636
CareLit-ID
Jahr
2024
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Abstract Background We aimed to investigate the rate of TBC reactivation in patients with autoinflammatory conditions who had been followed up under treatment with IL-1 antagonists in our clinic. We further aimed to evaluate whether latent TBC screening and isoniazid prophylaxis before IL-1 inhibitor treatment is beneficial in the prevention of reactivation. Patients and Methods This study was designed as a cross-sectional and observational study. It received the approval of the local ethics committee and was therefore performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsin…
Schlagworte
tuberculosis
familial Mediterranean fever
reactivation
autoinflammatory
interleukin-1
tuberkulose
familiäres Mittelmeerfieber
interleukin 1
reaktivierung
autoinflammatorisch
Aktuelle Rheumatologie
